Paper7207618
Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts.
Shih C and 3 others. Nature, 1981. Cited by 745 papers, by iCite.
Cite this record
ConductScience Library. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Papers, record 7207618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7207618
- Cell line
- EJ-6-2-Bam-6a1 paper
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Source Cell lines
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transformation, Neoplastic | Major topic |
| DNA, Neoplasm | Major topic |
| Genes | Major topic |
| Animals | |
| Carcinoma | |
| Cells, Cultured | |
| Fibroblasts | |
| Glioma | |
| Humans | |
| Lung Neoplasms | |
| Mice | |
| Neoplasms, Experimental | |
| Neuroblastoma | |
| Rabbits | |
| Rats | |
| Species Specificity | |
| Transfection | |
| Transformation, Genetic | |
| Urinary Bladder Neoplasms |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA14051 | NCI NIH HHS | United States | P01CA014051 | PubMed and NIH | NIH RePORTER |
| CA26717 | NCI NIH HHS | United States | P01CA026717 | PubMed and NIH | NIH RePORTER |
| P30CA014051 | NIH | NIH RePORTER |
Cited by198
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 745 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42165909 | Current evidence on the cell of origin of meningiomas disputes the arachnoid cap cell dogma. | Acta Neurochir (Wien) | 2026 | https://conductscience.org/library/papers/42165909 | PubMed |
| 42105364 | Mechanistic insights on spatiotemporal control of Ras-signaling. | Biol Chem | 2026 | https://conductscience.org/library/papers/42105364 | PubMed |
| 40862761 | HER2/neu as a Signaling and Therapeutic Marker in Uterine Serous Carcinoma. | Cells | 2025 | https://conductscience.org/library/papers/40862761 | PubMed |
| 39638567 | "Undruggable KRAS": druggable after all. | Genes Dev | 2025 | https://conductscience.org/library/papers/39638567 | PubMed |
| 39455281 | Molecular and cellular dynamics of squamous cell carcinomas across tissues. | Genes Dev | 2025 | https://conductscience.org/library/papers/39455281 | PubMed |
| 39020378 | HER3 receptor and its role in the therapeutic management of metastatic breast cancer. | J Transl Med | 2024 | https://conductscience.org/library/papers/39020378 | PubMed |
| 38539456 | HER2-Positive Early Breast Cancer: Time for Ultimate De-Escalation? | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38539456 | PubMed |
| 37306902 | Transforming Diagnosis and Therapeutics Using Cancer Genomics. | Cancer Treat Res | 2023 | https://conductscience.org/library/papers/37306902 | PubMed |
| 37110218 | Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence. | Metabolites | 2023 | https://conductscience.org/library/papers/37110218 | PubMed |
| 36890849 | Application of Immunohistochemistry in Clinical Practices as a Standardized Assay for Breast Cancer. | Acta Histochem Cytochem | 2023 | https://conductscience.org/library/papers/36890849 | PubMed |
| 36617643 | Emerging Therapies for Breast Cancer. | Cold Spring Harb Perspect Med | 2023 | https://conductscience.org/library/papers/36617643 | PubMed |
| 36512199 | Peto's paradox revisited: black box vs mechanistic approaches to understanding the roles of mutations and promoting factors in cancer. | Eur J Epidemiol | 2023 | https://conductscience.org/library/papers/36512199 | PubMed |
| 36344672 | Targeting HER2-positive breast cancer: advances and future directions. | Nat Rev Drug Discov | 2023 | https://conductscience.org/library/papers/36344672 | PubMed |
| 36165721 | HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer. | Cancer J | 2022 | https://conductscience.org/library/papers/36165721 | PubMed |
| 35731927 | Inactivating Amplified HER2: Challenges, Dilemmas, and Future Directions. | Cancer Res | 2022 | https://conductscience.org/library/papers/35731927 | PubMed |
| 35701396 | Identification, discrimination and heterogeneity of fibroblasts. | Nat Commun | 2022 | https://conductscience.org/library/papers/35701396 | PubMed |
| 35409064 | Small-Molecule RAS Inhibitors as Anticancer Agents: Discovery, Development, and Mechanistic Studies. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35409064 | PubMed |
| 35251632 | Breast microcalcifications: Past, present and future (Review). | Mol Clin Oncol | 2022 | https://conductscience.org/library/papers/35251632 | PubMed |
| 35045886 | The path to the clinic: a comprehensive review on direct KRASG12C inhibitors. | J Exp Clin Cancer Res | 2022 | https://conductscience.org/library/papers/35045886 | PubMed |
| 34946546 | Emerging Therapeutic Agents for Colorectal Cancer. | Molecules | 2021 | https://conductscience.org/library/papers/34946546 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7207618
GET https://conductscience.org/api/papers/v1/7207618/cited_by?page=2